Related Experiment Videos
Pharmacogenetics in clinical dermatology
M Ameen1, C H Smith, J N W N Barker
1Skin Therapy Research Unit, St John's Institute of Dermatology, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.
The British Journal of Dermatology
|February 14, 2002
Summary
Pharmacogenetics uses genetic differences to predict patient drug responses and toxicity in skin diseases. This approach promises safer, more effective treatments and improved healthcare delivery.
Area of Science:
- Dermatology
- Pharmacology
- Genetics
Background:
- Systemic therapies for skin diseases face challenges with drug toxicity and efficacy.
- Predicting severe adverse reactions like toxic epidermal necrolysis remains difficult.
Purpose of the Study:
- To explore the role of pharmacogenetics in optimizing systemic drug therapy for skin conditions.
- To identify methods for predicting individual patient responses and toxicity.
Main Methods:
- Leveraging advances in molecular genetic techniques, including high-throughput genotyping and microarrays.
- Applying pharmacogenetic principles to analyze genetic variations influencing drug response.
Main Results:
- Pharmacogenetics offers a pathway to differentiate drug responders from non-responders.
- It aids in predicting patients at risk for adverse drug reactions.
Conclusions:
- Pharmacogenetics enables rationalized drug therapy, enhancing safety and efficacy in dermatology.
- Future pharmacogenetic testing is expected to be practicable and economical.
- This field will impact drug selection, clinical trial design, and healthcare costs.